Carlos Prada MD

Dr. Carlos E. Prada, MD, finds it an honor to work with children, adults, and families with genetic diseases with a focus on lysosomal storage disorders, neurofibromatosis, rasopathies, and metabolic diseases. His clinical work is devoted to improving health for individuals with rare diseases by developing individualized and integrated care across specialties to promote their well-being. He has conducted randomized clinical trials of novel therapeutics, including gene therapy.

An author of over 100 publications, Dr. Prada has been the principal investigator on numerous federal and foundation grants, including grants from the Department of Defense (DoD), National Institute of Neurological Disorders and Stroke (NINDS), and the American College of Medical Genetics and Genomics (ACMG). He is the principal investigator for a large effort to develop novel biomarkers of tumor progression in neurofibromatosis type 1. He is also the principal investigator for mRNA therapies for Propionic acidemia, Methylmalonic acidemia, and gene therapy for lysosomal storage disorders. Dr. Prada served as the Associate Editor for the American Journal of Medical Genetics. He has an interest in international medicine and collaborates with the Cardiovascular Foundation of Colombia and the Dominican Republic.

As an advocate in genetics, he is passionate about helping build connections between families with rare genetic disorders to help develop foundations for future research and improve our understanding of disease and potential therapeutics. Educating the new generation of clinical and biochemical geneticists has been an area of focus. Dr. Prada has mentored numerous trainees who are now independent researchers and clinicians. Dr. Prada joined Lurie Children’s and the Feinberg School of Medicine at Northwestern University as the Head of the Edwards Family Division of Genetics & Rare Diseases. He also holds the position of the Edwards Family Chair of Genetics & Rare Diseases